Trial
NCT03456700
Auranofin and Sirolimus in Treating Participants With Ovarian Cancer
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Mayo Clinic
Collaborators
—
Condition
Ovarian Serous Tumor
Intervention
Auranofin
Why stopped
The study is closed per results from the interim analysis.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-05-08